IBDEI3AV ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.4) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.4,178,0)
;;=NEUROSTIMULATORS^8^29
;;^UTILITY(U,$J,358.4,179,0)
;;=SEIZURES/EPILEPSY/SPELLS^15^30
;;^UTILITY(U,$J,358.4,180,0)
;;=CEREBROVASCULAR DISEASE^2^30
;;^UTILITY(U,$J,358.4,181,0)
;;=DIZZINESS^3^30
;;^UTILITY(U,$J,358.4,182,0)
;;=ENCEPHALOPATHY^5^30
;;^UTILITY(U,$J,358.4,183,0)
;;=HEADACHE^6^30
;;^UTILITY(U,$J,358.4,184,0)
;;=MOVEMENT DISORDERS^8^30
;;^UTILITY(U,$J,358.4,185,0)
;;=NEOPLASMS^10^30
;;^UTILITY(U,$J,358.4,186,0)
;;=NEURODEGENERATIVE DISEASE^11^30
;;^UTILITY(U,$J,358.4,187,0)
;;=OTHER^13^30
;;^UTILITY(U,$J,358.4,188,0)
;;=CARDIAC DISORDERS^1^30
;;^UTILITY(U,$J,358.4,189,0)
;;=INFLAMMATORY & DEMYELINATING DISEASES^7^30
;;^UTILITY(U,$J,358.4,190,0)
;;=NEUROMUSCULAR DISORDERS^12^30
;;^UTILITY(U,$J,358.4,191,0)
;;=PAIN^14^30
;;^UTILITY(U,$J,358.4,192,0)
;;=SPINAL CONDITIONS^16^30
;;^UTILITY(U,$J,358.4,193,0)
;;=SYMPTOMS^18^30
;;^UTILITY(U,$J,358.4,194,0)
;;=VISION DISTURBANCES^19^30
;;^UTILITY(U,$J,358.4,195,0)
;;=EMG DX^4^30
;;^UTILITY(U,$J,358.4,196,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^17^30
;;^UTILITY(U,$J,358.4,197,0)
;;=MUSCLE ATROPHY^9^30
;;^UTILITY(U,$J,358.4,198,0)
;;=NEUROSURGERY PROCEDURES^1^31
;;^UTILITY(U,$J,358.4,199,0)
;;=PROLONGED SERVICE^2^31
;;^UTILITY(U,$J,358.4,200,0)
;;=NEW PATIENT^2^32
;;^UTILITY(U,$J,358.4,201,0)
;;=ESTABLISHED PATIENT^1^32
;;^UTILITY(U,$J,358.4,202,0)
;;=CONSULTATIONS^3^32
;;^UTILITY(U,$J,358.4,203,0)
;;=POST OP^4^32
;;^UTILITY(U,$J,358.4,204,0)
;;=HEAD/CEREBRAL^4^33
;;^UTILITY(U,$J,358.4,205,0)
;;=CERVICAL SPINE^1^33
;;^UTILITY(U,$J,358.4,206,0)
;;=THORACIC SPINE^10^33
;;^UTILITY(U,$J,358.4,207,0)
;;=LUMBO-SACRAL SPINE^5^33
;;^UTILITY(U,$J,358.4,208,0)
;;=EXTREMITIES^3^33
;;^UTILITY(U,$J,358.4,209,0)
;;=PERIPHERAL NERVE^8^33
;;^UTILITY(U,$J,358.4,210,0)
;;=CHRONIC PAIN^2^33
;;^UTILITY(U,$J,358.4,211,0)
;;=MISCELLANEOUS^6^33
;;^UTILITY(U,$J,358.4,212,0)
;;=NEOPLASM^7^33
;;^UTILITY(U,$J,358.4,213,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^9^33
;;^UTILITY(U,$J,358.4,214,0)
;;=ESTABLISHED PATIENT^1^34
;;^UTILITY(U,$J,358.4,215,0)
;;=CONSULTATION-CLINICIAN^2^34
;;^UTILITY(U,$J,358.4,216,0)
;;=NEW PATIENT^3^34
;;^UTILITY(U,$J,358.4,217,0)
;;=NEUROLYSIS^2^35
;;^UTILITY(U,$J,358.4,218,0)
;;=NEUROSTIMULATORS^3^35
;;^UTILITY(U,$J,358.4,219,0)
;;=OTHER PROCEDURES^4^35
;;^UTILITY(U,$J,358.4,220,0)
;;=SPINAL PROCEDURES/NERVE BLOCKS^6^35
;;^UTILITY(U,$J,358.4,221,0)
;;=TEAM CONFERENCE^7^35
;;^UTILITY(U,$J,358.4,222,0)
;;=PROLONGED SERVICES^5^35
;;^UTILITY(U,$J,358.4,223,0)
;;=ACUPUNCTURE/DRY NEEDLING^1^35
;;^UTILITY(U,$J,358.4,224,0)
;;=ABDOMINAL PAIN^1^36
;;^UTILITY(U,$J,358.4,225,0)
;;=CARDIAC^2^36
;;^UTILITY(U,$J,358.4,226,0)
;;=DIGESTIVE SYSTEM DISEASES^4^36
;;^UTILITY(U,$J,358.4,227,0)
;;=NERVOUS SYSTEM DISEASES^9^36
;;^UTILITY(U,$J,358.4,228,0)
;;=GENERAL SIGNS & SYMPTOMS^5^36
;;^UTILITY(U,$J,358.4,229,0)
;;=INFECTIOUS DISEASES^6^36
;;^UTILITY(U,$J,358.4,230,0)
;;=MALIGNANT NEOPLASMS^7^36
;;^UTILITY(U,$J,358.4,231,0)
;;=OTHER^10^36
;;^UTILITY(U,$J,358.4,232,0)
;;=PRE/POST SURGERY^11^36
;;^UTILITY(U,$J,358.4,233,0)
;;=RESPIRATORY^12^36
;;^UTILITY(U,$J,358.4,234,0)
;;=MIGRAINE^8^36
;;^UTILITY(U,$J,358.4,235,0)
;;=SUICIDE IDEATION/ATTEMPTS^13^36
;;^UTILITY(U,$J,358.4,236,0)
;;=CHRONIC PAIN DUE TO^3^36
;;^UTILITY(U,$J,358.4,237,0)
;;=ASPIRATION/INJECTION^1^37
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3AV 3764 printed Apr 09, 2024@21:06:33 Page 2
IBDEI3AV ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.4)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.4,178,0)
+2 ;;=NEUROSTIMULATORS^8^29
+3 ;;^UTILITY(U,$J,358.4,179,0)
+4 ;;=SEIZURES/EPILEPSY/SPELLS^15^30
+5 ;;^UTILITY(U,$J,358.4,180,0)
+6 ;;=CEREBROVASCULAR DISEASE^2^30
+7 ;;^UTILITY(U,$J,358.4,181,0)
+8 ;;=DIZZINESS^3^30
+9 ;;^UTILITY(U,$J,358.4,182,0)
+10 ;;=ENCEPHALOPATHY^5^30
+11 ;;^UTILITY(U,$J,358.4,183,0)
+12 ;;=HEADACHE^6^30
+13 ;;^UTILITY(U,$J,358.4,184,0)
+14 ;;=MOVEMENT DISORDERS^8^30
+15 ;;^UTILITY(U,$J,358.4,185,0)
+16 ;;=NEOPLASMS^10^30
+17 ;;^UTILITY(U,$J,358.4,186,0)
+18 ;;=NEURODEGENERATIVE DISEASE^11^30
+19 ;;^UTILITY(U,$J,358.4,187,0)
+20 ;;=OTHER^13^30
+21 ;;^UTILITY(U,$J,358.4,188,0)
+22 ;;=CARDIAC DISORDERS^1^30
+23 ;;^UTILITY(U,$J,358.4,189,0)
+24 ;;=INFLAMMATORY & DEMYELINATING DISEASES^7^30
+25 ;;^UTILITY(U,$J,358.4,190,0)
+26 ;;=NEUROMUSCULAR DISORDERS^12^30
+27 ;;^UTILITY(U,$J,358.4,191,0)
+28 ;;=PAIN^14^30
+29 ;;^UTILITY(U,$J,358.4,192,0)
+30 ;;=SPINAL CONDITIONS^16^30
+31 ;;^UTILITY(U,$J,358.4,193,0)
+32 ;;=SYMPTOMS^18^30
+33 ;;^UTILITY(U,$J,358.4,194,0)
+34 ;;=VISION DISTURBANCES^19^30
+35 ;;^UTILITY(U,$J,358.4,195,0)
+36 ;;=EMG DX^4^30
+37 ;;^UTILITY(U,$J,358.4,196,0)
+38 ;;=SUICIDE IDEATIONS/ATTEMPTS^17^30
+39 ;;^UTILITY(U,$J,358.4,197,0)
+40 ;;=MUSCLE ATROPHY^9^30
+41 ;;^UTILITY(U,$J,358.4,198,0)
+42 ;;=NEUROSURGERY PROCEDURES^1^31
+43 ;;^UTILITY(U,$J,358.4,199,0)
+44 ;;=PROLONGED SERVICE^2^31
+45 ;;^UTILITY(U,$J,358.4,200,0)
+46 ;;=NEW PATIENT^2^32
+47 ;;^UTILITY(U,$J,358.4,201,0)
+48 ;;=ESTABLISHED PATIENT^1^32
+49 ;;^UTILITY(U,$J,358.4,202,0)
+50 ;;=CONSULTATIONS^3^32
+51 ;;^UTILITY(U,$J,358.4,203,0)
+52 ;;=POST OP^4^32
+53 ;;^UTILITY(U,$J,358.4,204,0)
+54 ;;=HEAD/CEREBRAL^4^33
+55 ;;^UTILITY(U,$J,358.4,205,0)
+56 ;;=CERVICAL SPINE^1^33
+57 ;;^UTILITY(U,$J,358.4,206,0)
+58 ;;=THORACIC SPINE^10^33
+59 ;;^UTILITY(U,$J,358.4,207,0)
+60 ;;=LUMBO-SACRAL SPINE^5^33
+61 ;;^UTILITY(U,$J,358.4,208,0)
+62 ;;=EXTREMITIES^3^33
+63 ;;^UTILITY(U,$J,358.4,209,0)
+64 ;;=PERIPHERAL NERVE^8^33
+65 ;;^UTILITY(U,$J,358.4,210,0)
+66 ;;=CHRONIC PAIN^2^33
+67 ;;^UTILITY(U,$J,358.4,211,0)
+68 ;;=MISCELLANEOUS^6^33
+69 ;;^UTILITY(U,$J,358.4,212,0)
+70 ;;=NEOPLASM^7^33
+71 ;;^UTILITY(U,$J,358.4,213,0)
+72 ;;=SUICIDE IDEATIONS/ATTEMPTS^9^33
+73 ;;^UTILITY(U,$J,358.4,214,0)
+74 ;;=ESTABLISHED PATIENT^1^34
+75 ;;^UTILITY(U,$J,358.4,215,0)
+76 ;;=CONSULTATION-CLINICIAN^2^34
+77 ;;^UTILITY(U,$J,358.4,216,0)
+78 ;;=NEW PATIENT^3^34
+79 ;;^UTILITY(U,$J,358.4,217,0)
+80 ;;=NEUROLYSIS^2^35
+81 ;;^UTILITY(U,$J,358.4,218,0)
+82 ;;=NEUROSTIMULATORS^3^35
+83 ;;^UTILITY(U,$J,358.4,219,0)
+84 ;;=OTHER PROCEDURES^4^35
+85 ;;^UTILITY(U,$J,358.4,220,0)
+86 ;;=SPINAL PROCEDURES/NERVE BLOCKS^6^35
+87 ;;^UTILITY(U,$J,358.4,221,0)
+88 ;;=TEAM CONFERENCE^7^35
+89 ;;^UTILITY(U,$J,358.4,222,0)
+90 ;;=PROLONGED SERVICES^5^35
+91 ;;^UTILITY(U,$J,358.4,223,0)
+92 ;;=ACUPUNCTURE/DRY NEEDLING^1^35
+93 ;;^UTILITY(U,$J,358.4,224,0)
+94 ;;=ABDOMINAL PAIN^1^36
+95 ;;^UTILITY(U,$J,358.4,225,0)
+96 ;;=CARDIAC^2^36
+97 ;;^UTILITY(U,$J,358.4,226,0)
+98 ;;=DIGESTIVE SYSTEM DISEASES^4^36
+99 ;;^UTILITY(U,$J,358.4,227,0)
+100 ;;=NERVOUS SYSTEM DISEASES^9^36
+101 ;;^UTILITY(U,$J,358.4,228,0)
+102 ;;=GENERAL SIGNS & SYMPTOMS^5^36
+103 ;;^UTILITY(U,$J,358.4,229,0)
+104 ;;=INFECTIOUS DISEASES^6^36
+105 ;;^UTILITY(U,$J,358.4,230,0)
+106 ;;=MALIGNANT NEOPLASMS^7^36
+107 ;;^UTILITY(U,$J,358.4,231,0)
+108 ;;=OTHER^10^36
+109 ;;^UTILITY(U,$J,358.4,232,0)
+110 ;;=PRE/POST SURGERY^11^36
+111 ;;^UTILITY(U,$J,358.4,233,0)
+112 ;;=RESPIRATORY^12^36
+113 ;;^UTILITY(U,$J,358.4,234,0)
+114 ;;=MIGRAINE^8^36
+115 ;;^UTILITY(U,$J,358.4,235,0)
+116 ;;=SUICIDE IDEATION/ATTEMPTS^13^36
+117 ;;^UTILITY(U,$J,358.4,236,0)
+118 ;;=CHRONIC PAIN DUE TO^3^36
+119 ;;^UTILITY(U,$J,358.4,237,0)
+120 ;;=ASPIRATION/INJECTION^1^37
